Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Richon

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cancer Research|July 1, 1997
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cellsV M Richon, P Russo, G Venta-Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylasesV M Richon, S Emiliani, E Verdin, et al.
Molecular and Cellular Biology|July 1, 1990
Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cellsJ Michaeli, Y B Lebedev, V M Richon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1991
Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiationV M Richon, N Weich, L Leng, et al.
Cancer Research|November 15, 1993
Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiationL Leng, F Yu, L Dong, et al.
Journal of the National Cancer Institute|May 26, 1999
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterizationF Rabbani, V M Richon, I Orlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cellsD S Siegel, X Zhang, R Feinman, et al.
Nature|September 18, 1999
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitorsM S Finnin, J R Donigian, A Cohen, et al.
Cancer Research|September 15, 1999
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastomaR D Glick, S L Swendeman, D C Coffey, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Second generation hybrid polar compounds are potent inducers of transformed cell differentiationV M Richon, Y Webb, R Merger, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer Research|July 1, 1997
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cellsV M Richon, P Russo, G Venta-Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylasesV M Richon, S Emiliani, E Verdin, et al.
Molecular and Cellular Biology|July 1, 1990
Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cellsJ Michaeli, Y B Lebedev, V M Richon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1991
Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiationV M Richon, N Weich, L Leng, et al.
Cancer Research|November 15, 1993
Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiationL Leng, F Yu, L Dong, et al.
Journal of the National Cancer Institute|May 26, 1999
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterizationF Rabbani, V M Richon, I Orlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cellsD S Siegel, X Zhang, R Feinman, et al.
Nature|September 18, 1999
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitorsM S Finnin, J R Donigian, A Cohen, et al.
Cancer Research|September 15, 1999
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastomaR D Glick, S L Swendeman, D C Coffey, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Second generation hybrid polar compounds are potent inducers of transformed cell differentiationV M Richon, Y Webb, R Merger, et al.
Pageof 5